Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model

被引：33

作者：

Wu, Jianjun ^{[1
]}

Yu, Wenbo ^{[1
]}

Chen, Yan ^{[1
]}

Su, Yaru ^{[1
]}

Ding, Zhengtong ^{[1
]}

Ren, Huimin ^{[1
]}

Jiang, Yuping ^{[1
]}

Wang, Jian ^{[1
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China

来源：

NEUROCHEMICAL RESEARCH | 2010年 / 35卷 / 03期

基金：

上海市自然科学基金;

关键词：

Parkinson's disease; Glial cell line-derived neurotrophic factor; Lentivirus; Gene therapy; Bone marrow stromal cells; Lactacystin; MARROW STROMAL CELLS; RETRACTED ARTICLE. SEE; ALPHA-SYNUCLEIN; NEUROTROPHIC FACTOR; DISEASE; IMPAIRMENT; PATHOLOGY; DELIVERY; FORM;

D O I：

10.1007/s11064-009-0086-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The potential value of glial cell line-derived neurotrophic factor (GDNF) in treating Parkinson's disease (PD) remains controversial. In order to evaluate the therapeutic effect of GDNF-engineered bone marrow stromal cells (BMSCs) in parkinsonian rat model, GDNF-BMSCs and LacZ-BMSCs were transplanted into striatum and followed by Lactacystin lesioning at median forebrain bundles 1 week later. We observed that the intrastriatal transplantation of GDNF-BMSCs could significantly rescue the dopaminergic neurons from lactacystin-induced neurotoxicity with regard to behavioral recovery, tyrosine hydroxylase level in nigra and striatum, and striatal dopamine level. We interpret the outcomes that intrastriatal transplantation of GDNF-BMSCs might be beneficial in the treatment of PD.

引用

页码：495 / 502

页数：8

共 35 条

[1] Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson's Disease [J].

Bahat-Stroomza, Merav ;

Barhum, Yael ;

Levy, Yossef S. ;

Karpov, Olga ;

Bulvik, Shlomo ;

Melamed, Eldad ;

Offen, Daniel .

JOURNAL OF MOLECULAR NEUROSCIENCE, 2009, 39 (1-2) :199-210

[2] Transplantation of bone marrow stromal cells for peripheral nerve repair [J].

Chen, Chun-Jung ;

Ou, Yen-Chuan ;

Liao, Su-Lan ;

Chen, Wen-Ying ;

Chen, Shih-Yun ;

Wu, Ching-Wen ;

Wang, Chun-Chiang ;

Wang, Wen-Yi ;

Huang, Yong-San ;

Hsu, Shan-Hui .

EXPERIMENTAL NEUROLOGY, 2007, 204 (01) :443-453

[3] The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders [J].

Chung, KKK ;

Dawson, VL ;

Dawson, TM .

TRENDS IN NEUROSCIENCES, 2001, 24 (11) :S7-S14

[4] Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets [J].

Costa, S ;

Iravani, MM ;

Pearce, RKB ;

Jenner, P .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (01) :45-50

[5] Emerging restorative treatments for Parkinson's disease [J].

Deierborg, Tomas ;

Soulet, Denis ;

Roybon, Laurent ;

Hall, Vanessa ;

Brundin, Patrik .

PROGRESS IN NEUROBIOLOGY, 2008, 85 (04) :407-432

[6] Modeling Parkinsn's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway [J].

Deumens, R ;

Blokland, A ;

Prickaerts, J .

EXPERIMENTAL NEUROLOGY, 2002, 175 (02) :303-317

[7] Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation [J].

Dezawa, M ;

Kanno, H ;

Hoshino, M ;

Cho, H ;

Matsumoto, N ;

Itokazu, Y ;

Tajima, N ;

Yamada, H ;

Sawada, H ;

Ishikawa, H ;

Mimura, T ;

Kitada, M ;

Suzuki, Y ;

Ide, C .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (12) :1701-1710

[8]

Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507

[9] Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease [J].

Dietz, GPH ;

Valbuena, PC ;

Dietz, B ;

Meuer, K ;

Müller, P ;

Weishaupt, JH ;

Bähr, M .

BRAIN RESEARCH, 2006, 1082 :61-66

[10] Synucleinopathies - Clinical and pathological implications [J].

Galvin, JE ;

Lee, VMY ;

Trojanowski, JQ .

ARCHIVES OF NEUROLOGY, 2001, 58 (02) :186-190

← 1 2 3 4 →